For Duchenne muscular dystrophy (DMD) which can be caused by any 1 of the more than 2000 different mutations in the DMD gene, cell therapy offers potential benefits regardless of the exact genetic mutation which can vary from patient to patient (Blau and Daley, 2019; Biressi et al., 2020). This evidence concerns the gene DMD and Duchenne muscular dystrophy.